Breast Cancer Profiling Project, Drug Sensitivity phase I: Fixed-cell GR measures of 35 breast cell lines to 34 small molecule perturbagens from library plate I. Dataset 1 of 2: Normalized growth rate inhibition values - Dataset (ID:20343)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Primary Target | Pathway | Mean Normalized Growth Rate Inhibition Value | Increased Fraction Dead |
|---|---|---|---|---|---|---|
| HCC70 | Cediranib | 0.1 | VEGFR/cKIT | RTK | 1.0387 | 0.00783 |
| Hs 578T | Cediranib | 0.31623 | VEGFR/cKIT | RTK | 0.5611 | 0.05612 |
| HCC1806 | Cediranib | 0.001 | VEGFR/cKIT | RTK | 0.9923 | 0.00046 |
| PDX1328 | Cediranib | 0.31623 | VEGFR/cKIT | RTK | 0.7518 | 0.03146 |
| PDX1328 | Cediranib | 1.0 | VEGFR/cKIT | RTK | 0.4108 | 0.06879 |
| MDA-MB-436 | Cediranib | 3.1623 | VEGFR/cKIT | RTK | 0.6392 | 0.00639 |
| CAL-120 | Cediranib | 0.001 | VEGFR/cKIT | RTK | 0.9493 | -0.00088 |
| PDX1328 | Cediranib | 3.1623 | VEGFR/cKIT | RTK | 0.0951 | 0.12170 |
| PDX1328 | Cediranib | 10.0 | VEGFR/cKIT | RTK | -0.8534 | 0.62581 |
| HCC1954 | Cediranib | 1.0 | VEGFR/cKIT | RTK | 1.0082 | -0.00324 |